Oncology Ventures
VC Fund
New York, United States
Oncology Ventures is a VC fund in New York focused on Health Care and Medical. Oncology Ventures will make investments in cancer-focused data, infrastructure, IT, and services start-ups with the goal of fundamentally changing the way cancer treatment is conceived and provided at scale. Our fund will not invest in pharmaceuticals, therapies, or medical devices.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 18%
- Fund size:
- $62M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Oncology Ventures invests in
Stages Oncology Ventures invests in
Countries Oncology Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1M–$12M
- Series A
- $8M–$20M
- Series B
- $18M–$22M
Investment Focus
Industry
- Health Care 7 (41%)
- Medical 4 (24%)
- Internet 2 (12%)
- Biopharma 2 (12%)
- Therapeutics 2 (12%)
Stage
- Series A 6 (35%)
- Seed 5 (29%)
- Series B 2 (12%)
- Venture - Series Unknown 2 (12%)
Country
- United States 8 (47%)
- India 1 (6%)
- Argentina 1 (6%)
- United Kingdom 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ben Freeberg
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 11 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Triomics is a generative AI-powered platform that matches patients to clinical trials. The company advances oncology research and care operations by aiding in accelerating trial enrollment, quality improvement projects, and streamlining healthcare operations, among other functions. It's trusted and validated foundational oncology AI, trainedto comprehend health records and medical terminology, underpins this critical mission. | $22M / Series B / May 27, 2026 | ||
| Bringing Self-Service AI to the Life Sciences | $4.5M / Seed / May 06, 2026 | ||
| NexCure offers clinically intense therapies in outpatient, community settings, revolutionizing the delivery, monitoring, and scaling of CAR-T and other cutting-edge treatments. | $19M / Series A / Mar 05, 2026 | ||
| CancerNavigator offers cancer navigation and analytics, connecting patients with care experts and providing personalized support. | $7M / Venture - Series Unknown / Feb 18, 2026 | ||
| We exist for humanity 2Win. Pioneering BOSS [Business (Operating System) as Service]. Trusted by Top Oncologists, we serve mission critical enterprises. Transforming key operations with AI-driven discipline. Headquartered in Silicon Valley, RISA has offices across the globe. | $11.1M / Series A / Jan 13, 2026 | ||
| BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment. | $8M / Series A / Jan 12, 2026 | ||
| WellBeam is an operator of a connected care platform intended to help hospitals connect with third party clients. | $10M / Series A / Nov 19, 2025 | ||
| Lumonous is a healthcare company that offers Radiation Oncology, Radiation Therapy, and Cancer treatment technology-enabled services. | $18.2M / Series B / Nov 06, 2025 | ||
| Daymark Health is a cancer care company that focuses on providing in-home and virtual supportive care to cancer patients in collaboration with health plans. The company offers a wide range of supportive care services, including behavioral health care and social support, aimed at meeting the comprehensive needs of cancer patients. Daymark Healthconnects primary care physicians, oncologists, and other care teams to create a seamless and supportive experience for patients, leveraging both virtual and home-based care methodologies. | $20M / Series A / Sep 25, 2025 | ||
| Ignite is the UK’s leading provider of technology-driven Patient Recruitment and Real-World Evidence solutions. | $10.9M / Series A / Aug 14, 2025 | ||
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Oncology Ventures invest in?
Oncology Ventures invests primarily in Health Care, Medical and Internet startups, most often at Series A and Seed stage. Most of the 17 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Oncology Ventures's check size?
Oncology Ventures typically joins rounds of $1M–$12M at Seed, $8M–$20M at Series A and $18M–$22M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Oncology Ventures participates in.
How do I contact Oncology Ventures?
Public channels for Oncology Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Oncology Ventures?
The team at Oncology Ventures includes Ben Freeberg (Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
